Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Short-term Clinical Deterioration After Acute Pulmonary Embolism

ClinicalTrials.gov ID: NCT03915925

Public ClinicalTrials.gov record NCT03915925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03915925
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Wake Forest University Health Sciences
Other
Enrollment
935 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2018
Primary completion
Nov 29, 2020
Completion
Nov 29, 2020
Last update posted
Apr 26, 2022

2018 – 2020

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
San Diego Medical Center San Diego California 92120
Christiana Care Health System Newark Delaware 19718
Orlando Regional Medical Center Orlando Florida 32806
Carolinas Medical Center - Main Charlotte North Carolina 28203
Vanderbilt Medical Center Nashville Tennessee 37232
Univeristy of Utah Hospital Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03915925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03915925 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →